DENTSPLY SIRONA (XRAY) director Mazelsky receives 22,822-share RSU equity grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Jonathan Jay Mazelsky reported receiving an equity award of 22,822 shares of Common Stock in the form of Restricted Stock Units. The grant was recorded at no cash price per share and is classified as a grant or award acquisition rather than an open-market purchase or sale.

The RSUs vest in full one year from the grant date, meaning the restrictions lapse after that period. Following this award, Mazelsky’s directly held Common Stock position reported in this filing increased to 51,668.534 shares, showing his updated ownership stake as reflected in this Form 4.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MAZELSKY JONATHAN JAY

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,822	$0.00	--

Holdings After Transaction: Common Stock — 51,668.534 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 22,822 shares Grant price: $0.0000 per share Post-grant holdings: 51,668.534 shares +1 more

4 metrics

RSU grant size 22,822 shares Restricted Stock Units granted to Jonathan Jay Mazelsky

Grant price $0.0000 per share Stated cash price per share for RSU award

Post-grant holdings 51,668.534 shares Total Common Stock held directly after the transaction

Vesting period One year from grant date RSUs vest in full after one year

Key Terms

Restricted Stock Units (RSUs), Grant, award, or other acquisition, Form 4, Common Stock

4 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"showing his updated ownership stake as reflected in this Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"received an equity award of 22,822 shares of Common Stock in the form of Restricted Stock Units"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/05/2026 - 05:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MAZELSKY JONATHAN JAY

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

NORTH CAROLINA

28277

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/03/2026		A		22,822⁽¹⁾	A	$0	51,668.534	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Jonathan Jay Mazelsky	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Jonathan Jay Mazelsky?

DENTSPLY SIRONA reported that director Jonathan Jay Mazelsky received an equity grant of 22,822 shares of Common Stock in the form of Restricted Stock Units. The award is a compensation-related grant, not an open-market trade, and is recorded with a zero cash price per share.

How many DENTSPLY SIRONA (XRAY) shares does Mazelsky hold after this Form 4 grant?

After the reported grant, Jonathan Jay Mazelsky holds 51,668.534 shares of DENTSPLY SIRONA Common Stock directly. This figure includes the newly awarded 22,822 Restricted Stock Units as reflected in the filing’s post-transaction ownership total for his direct holdings.

Is Mazelsky’s DENTSPLY SIRONA (XRAY) RSU grant an open-market purchase or sale?

The transaction is a compensation grant, not an open-market purchase or sale. It is coded as a grant, award, or other acquisition, with 22,822 Restricted Stock Units awarded at a stated cash price per share of zero, reflecting stock-based compensation rather than trading activity.

When do Jonathan Jay Mazelsky’s DENTSPLY SIRONA (XRAY) RSUs vest?

The Restricted Stock Units granted to Jonathan Jay Mazelsky vest in full one year from the grant date. At that time, the restrictions lapse on all 22,822 units, aligning the award with a one-year service-based vesting schedule disclosed in the footnote.

What does the transaction code "A" mean in the DENTSPLY SIRONA (XRAY) Form 4?

The transaction code "A" in this Form 4 indicates a grant, award, or other acquisition of securities. For DENTSPLY SIRONA, it reflects the issuance of 22,822 Restricted Stock Units to director Jonathan Jay Mazelsky as part of his equity compensation.